The potential impact of expanding target age groups for polio immunization campaigns
- PMID: 24472313
- PMCID: PMC3918103
- DOI: 10.1186/1471-2334-14-45
The potential impact of expanding target age groups for polio immunization campaigns
Abstract
Background: Global efforts to eradicate wild polioviruses (WPVs) continue to face challenges due to uninterrupted endemic WPV transmission in three countries and importation-related outbreaks into previously polio-free countries. We explore the potential role of including older children and adults in supplemental immunization activities (SIAs) to more rapidly increase population immunity and prevent or stop transmission.
Methods: We use a differential equation-based dynamic poliovirus transmission model to analyze the epidemiological impact and vaccine resource implications of expanding target age groups in SIAs. We explore the use of older age groups in SIAs for three situations: alternative responses to the 2010 outbreak in Tajikistan, retrospective examination of elimination in two high-risk states in northern India, and prospective and retrospective strategies to accelerate elimination in endemic northwestern Nigeria. Our model recognizes the ability of individuals with waned mucosal immunity (i.e., immunity from a historical live poliovirus infection) to become re-infected and contribute to transmission to a limited extent.
Results: SIAs involving expanded age groups reduce overall caseloads, decrease transmission, and generally lead to a small reduction in the time to achieve WPV elimination. Analysis of preventive expanded age group SIAs in Tajikistan or prior to type-specific surges in incidence in high-risk areas of India and Nigeria showed the greatest potential benefits of expanded age groups. Analysis of expanded age group SIAs in outbreak situations or to accelerate the interruption of endemic transmission showed relatively less benefit, largely due to the circulation of WPV reaching individuals sooner or more effectively than the SIAs. The India and Nigeria results depend strongly on how well SIAs involving expanded age groups reach relatively isolated subpopulations that sustain clusters of susceptible children, which we assume play a key role in persistent endemic WPV transmission in these areas.
Conclusions: This study suggests the need to carefully consider the epidemiological situation in the context of decisions to use expanded age group SIAs. Subpopulations of susceptible individuals may independently sustain transmission, which will reduce the overall benefits associated with using expanded age group SIAs to increase population immunity to a sufficiently high level to stop transmission and reduce the incidence of paralytic cases.
Figures
Similar articles
-
Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India.J Infect Dis. 2014 Nov 1;210 Suppl 1:S398-411. doi: 10.1093/infdis/jit844. J Infect Dis. 2014. PMID: 25316861
-
Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.PLoS One. 2015 Jun 11;10(6):e0130123. doi: 10.1371/journal.pone.0130123. eCollection 2015. PLoS One. 2015. PMID: 26068928 Free PMC article.
-
Progress toward interruption of wild poliovirus transmission--worldwide, January 2010-March 2011.MMWR Morb Mortal Wkly Rep. 2011 May 13;60(18):582-6. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21566559
-
The global polio eradication initiative: lessons learned and prospects for success.Vaccine. 2011 Dec 30;29 Suppl 4:D80-5. doi: 10.1016/j.vaccine.2011.10.005. Vaccine. 2011. PMID: 22486981 Review.
-
Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs).Expert Rev Vaccines. 2024 Jan-Dec;23(1):597-613. doi: 10.1080/14760584.2024.2361060. Epub 2024 Jun 7. Expert Rev Vaccines. 2024. PMID: 38813792 Review.
Cited by
-
Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria.Vaccine X. 2024 Mar 16;18:100476. doi: 10.1016/j.jvacx.2024.100476. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38617838 Free PMC article.
-
The status of immunization program and challenges in Ethiopia: A mixed method study.SAGE Open Med. 2024 Mar 21;12:20503121241237115. doi: 10.1177/20503121241237115. eCollection 2024. SAGE Open Med. 2024. PMID: 38516641 Free PMC article.
-
Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation.Gates Open Res. 2023 Apr 17;7:55. doi: 10.12688/gatesopenres.14511.1. eCollection 2023. Gates Open Res. 2023. PMID: 37547300 Free PMC article.
-
Global epidemiology of vaccine-derived poliovirus 2016-2021: A descriptive analysis and retrospective case-control study.EClinicalMedicine. 2022 Jun 25;50:101508. doi: 10.1016/j.eclinm.2022.101508. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35784443 Free PMC article.
-
Using integrated modeling to support the global eradication of vaccine-preventable diseases.Syst Dyn Rev. 2018 Jun;34(1-2):78-120. doi: 10.1002/sdr.1589. Syst Dyn Rev. 2018. PMID: 34552305 Free PMC article.
References
-
- Sutter RW, Kew OM, Cochi SL. In: Vaccines. Fifth edition. Plotkin SA, Orenstein WA, Offit PA, editor. Philadelphia: Saunders Elsevier; 2008. Poliovirus vaccine -- live.
-
- World Health Organization. Transmission of wild poliovirus type 2 - apparent global interruption. Wkly Epidemiol Rec. 2001;14:95–97. - PubMed
-
- Global Polio Eradication Initiative - list of wild poliovirus by country. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Wildpoli....
-
- World Health Assembly. Poliomyelitis: intensification of the global eradication initiative (resolution 65.5) Geneva, Switzerland: World Health Organization; 2012.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical